232 related articles for article (PubMed ID: 23661793)
1. Inhibiting the programmed death 1 pathway rescues Mycobacterium tuberculosis-specific interferon γ-producing T cells from apoptosis in patients with pulmonary tuberculosis.
Singh A; Mohan A; Dey AB; Mitra DK
J Infect Dis; 2013 Aug; 208(4):603-15. PubMed ID: 23661793
[TBL] [Abstract][Full Text] [Related]
2. Programmed death-1 receptor suppresses γ-IFN producing NKT cells in human tuberculosis.
Singh A; Dey AB; Mohan A; Mitra DK
Tuberculosis (Edinb); 2014 May; 94(3):197-206. PubMed ID: 24629634
[TBL] [Abstract][Full Text] [Related]
3. Programmed death-1
Singh A; Mohan A; Dey AB; Mitra DK
Clin Exp Immunol; 2017 Feb; 187(2):269-283. PubMed ID: 27665733
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of programmed death 1 ligand 1 on dendritic cells enhances Mycobacterium-mediated interferon γ (IFN-γ) production without modulating the frequencies of IFN-γ-producing CD4+ T cells.
Stephen-Victor E; Saha C; Sharma M; Holla S; Balaji KN; Kaveri SV; Bayry J
J Infect Dis; 2015 Mar; 211(6):1027-9. PubMed ID: 25258379
[No Abstract] [Full Text] [Related]
5. Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis.
Alvarez IB; Pasquinelli V; Jurado JO; Abbate E; Musella RM; de la Barrera SS; García VE
J Infect Dis; 2010 Aug; 202(4):524-32. PubMed ID: 20617899
[TBL] [Abstract][Full Text] [Related]
6. PD-1/PD-L pathway inhibits M.tb-specific CD4
Shen L; Gao Y; Liu Y; Zhang B; Liu Q; Wu J; Fan L; Ou Q; Zhang W; Shao L
Sci Rep; 2016 Dec; 6():38362. PubMed ID: 27924827
[TBL] [Abstract][Full Text] [Related]
7. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis.
Jurado JO; Alvarez IB; Pasquinelli V; Martínez GJ; Quiroga MF; Abbate E; Musella RM; Chuluyan HE; García VE
J Immunol; 2008 Jul; 181(1):116-25. PubMed ID: 18566376
[TBL] [Abstract][Full Text] [Related]
8. B Cells and Programmed Death-Ligand 2 Signaling Are Required for Maximal Interferon-γ Recall Response by Splenic CD4⁺ Memory T Cells of Mice Vaccinated with Mycobacterium tuberculosis Ag85B.
Riccomi A; Palma C
PLoS One; 2015; 10(9):e0137783. PubMed ID: 26379242
[TBL] [Abstract][Full Text] [Related]
9. PD-1 modulating Mycobacterium tuberculosis-specific polarized effector memory T cells response in tuberculosis pleurisy.
Li J; Jin C; Wu C; Huang J
J Leukoc Biol; 2019 Sep; 106(3):733-747. PubMed ID: 30861206
[TBL] [Abstract][Full Text] [Related]
10. PD-1/PD-Ls pathways between CD4(+) T cells and pleural mesothelial cells in human tuberculous pleurisy.
Yin W; Tong ZH; Cui A; Zhang JC; Ye ZJ; Yuan ML; Zhou Q; Shi HZ
Tuberculosis (Edinb); 2014 Mar; 94(2):131-9. PubMed ID: 24406080
[TBL] [Abstract][Full Text] [Related]
11. CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease.
Sakai S; Kauffman KD; Sallin MA; Sharpe AH; Young HA; Ganusov VV; Barber DL
PLoS Pathog; 2016 May; 12(5):e1005667. PubMed ID: 27244558
[TBL] [Abstract][Full Text] [Related]
12. Foxp3+ regulatory T cells among tuberculosis patients: impact on prognosis and restoration of antigen specific IFN-γ producing T cells.
Singh A; Dey AB; Mohan A; Sharma PK; Mitra DK
PLoS One; 2012; 7(9):e44728. PubMed ID: 23028594
[TBL] [Abstract][Full Text] [Related]
13. IFN-γ decreased the suppressive function of CD33
Zhan X; Hu S; Wu Y; Li M; Liu T; Ming S; Wu M; Liu M; Huang X
Mol Immunol; 2018 Feb; 94():107-120. PubMed ID: 29291452
[TBL] [Abstract][Full Text] [Related]
14. Reply to Stephen-Victor et al.
Mitra DK; Singh A; Mohan A; Dey AB
J Infect Dis; 2015 Mar; 211(6):1029-31. PubMed ID: 25258378
[No Abstract] [Full Text] [Related]
15. BATF Potentially Mediates Negative Regulation of PD-1/PD-Ls Pathway on T Cell Functions in
Liu Q; Ou Q; Shen L; Qiu C; Zhang B; Zhang W; Shao L; Gao Y; Chen ZW
Front Immunol; 2019; 10():2430. PubMed ID: 31681314
[No Abstract] [Full Text] [Related]
16. Improved Mycobacterium tuberculosis clearance after the restoration of IFN-γ
Kamboj D; Gupta P; Basil MV; Mohan A; Guleria R; Bhatnagar A; Mehta G; Kumar P; Saurabh A; Deepak R; Thakral D; Misra P; Tandon R; Gupta UD; Mitra DK
Eur J Immunol; 2020 May; 50(5):736-747. PubMed ID: 32113187
[TBL] [Abstract][Full Text] [Related]
17. Programmed death 1 lives up to its reputation in active tuberculosis.
Sable SB
J Infect Dis; 2013 Aug; 208(4):541-3. PubMed ID: 23661796
[No Abstract] [Full Text] [Related]
18. Interferon-γ upregulates Δ42PD1 expression on human monocytes via the PI3K/AKT pathway.
Cheng L; Tang X; Xu L; Zhang L; Shi H; Peng Q; Zhao F; Zhou Y; He Y; Wang H; Zhou B; Gao Z; Chen Z
Immunobiology; 2019 May; 224(3):388-396. PubMed ID: 30846331
[TBL] [Abstract][Full Text] [Related]
19. KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults.
Boer MC; van Meijgaarden KE; Goletti D; Vanini V; Prins C; Ottenhoff TH; Joosten SA
Tuberculosis (Edinb); 2016 Mar; 97():163-71. PubMed ID: 26750180
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation.
Chen N; Fang W; Zhan J; Hong S; Tang Y; Kang S; Zhang Y; He X; Zhou T; Qin T; Huang Y; Yi X; Zhang L
J Thorac Oncol; 2015 Jun; 10(6):910-23. PubMed ID: 25658629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
